Back to Trials
NCT03683680NARecruiting

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Dana-Farber Cancer Institute

Start Date

10/31/2018

Completion Date

10/1/2030

Summary

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Detailed Description

The purpose of this research study is to test a new method for determining the stage and prognosis of patients with malignant pleural mesothelioma. Currently, it is not possible to accurately determine cancer stage prior to surgery or another treatment. This new method may allow doctors to better classify cancer stage and give a better estimate for prognosis prior to surgery or another treatment. In this research study, the investigators would like to use biopsied tissue to study certain characteristics that will help test the new method for determining cancer stage and estimating prognosis. In this research study, the investigators are... * Obtaining pleural specimens at the time of routine diagnostic biopsy during the participant's standard treatment. * Storing your biopsied tissue * Studying the tissue to determine if the new method of staging and prognosis is accurate and valid

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * All adult patients with a diagnosis of malignant pleural mesothelioma undergoing * diagnostic pleural biopsy * pleuroscopy * and/or VATS resections * Participants must be 18 years of age or older. Exclusion Criteria: -Any patient who is found to be unsuitable for * surgery, * treatment * diagnosis,

Interventions

OTHER

MPT Test

OTHER

CLDN15/VIM Test

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Mesothelioma

Locations

Brigham and Women's Hospital

Boston, Massachusetts 02215

United States